Oncology & Cancer

KRAS mutations linked to brain arteriovenous malformations

(HealthDay)—Many patients with arteriovenous malformations of the brain have somatic activating KRAS mutations, according to a study published online Jan. 3 in the New England Journal of Medicine.

Oncology & Cancer

Cancer drug design targeted by COSMIC's new 3-D system

COSMIC-3D, the most comprehensive system for exploring cancer mutations in three dimensions, is launched today by COSMIC, based at the Wellcome Trust Sanger Institute, in collaboration with Astex Pharmaceuticals, Cambridge, ...

Oncology & Cancer

How TP53 gene loss drives gastric cancer evolution

Gastric cancer (GC) ranks as the fifth-most common and fourth-deadliest cancer worldwide, presenting significant health challenges, particularly in China, where it is most prevalent and accounts for nearly half of newly diagnosed ...

page 11 from 12